The Sexual Health of Rectal Cancer Patients - Full Text View

Sponsors and Collaborators:	Memorial Sloan-Kettering Cancer Center Albert Einstein College of Medicine of Yeshiva University Mount Sinai School of Medicine National Cancer Institute (NCI)
Information provided by:	Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:	NCT00712751

Purpose

We know that treatment for rectal cancer can impact women's sexual function. Cancer patients seek counseling for lots of reasons. It often helps them cope because they can express their feelings with a trained professional. This study is open to women who have been treated for rectal cancer. It involves a new type of counseling. It will teach women skills that they can use to improve their sex lives. These skills may also improve physical and emotional well-being. We will compare the new type of counseling with the standard care women receive after treatment for rectal cancer.

Condition	Intervention
Rectal Cancer Rectum	Behavioral: questionnaires Behavioral: CSI-SH- Cancer Survivorship Intervention

MedlinePlus related topics: Cancer

Drug Information available for: BaseLine

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	The Sexual Health of Rectal Cancer Patients: A Pilot Study

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:

To investigate the feasibility, tolerability, acceptability (including adherence) and efficacy of CSI-SH, a psycho-educational intervention, on the primary outcome of sexual functioning among female RC survivors. [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

To investigate the impact of CSI-SH on secondary outcomes: sexual self-concept, cancer specific distress, and general distress symptoms, as well as Quality of Life. [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]
To explore baseline variables that may influence the effectiveness of CSI-SH (i.e., moderators such as socio-demographic and medical variables). [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	80
Study Start Date:	June 2008
Estimated Study Completion Date:	June 2010
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
1 usual care (UC) which is the standard care that patients receive	Behavioral: questionnaires Participants randomized to the Usual Care arm will receive standard care (the care that participants receive who are not in the intervention). These individuals will not receive any additional therapy sessions from the study interventionists until they are done with the follow up interviews and then it will be offered to them. Follow up questionnaires will assess all study participants at 2 and 4 months after baseline.
2 Cancer Survivorship Intervention-Sexual Health (CSI-SH)plus Usual Care (US)	Behavioral: CSI-SH- Cancer Survivorship Intervention This involves four 1-hour face-to-face individual sessions with three additional telephone booster/review sessions provided in between the four face-to-face sessions.The face-to-face sessions also include homework assignments that will be reviewed at the subsequent session. Topics covered in the face-to-face sessions are reviewed in the booster telephone calls with the participant the following week. These telephone calls serve as a practice reminder for the participant as well as to help the participant reduce any barriers to implementing the session strategies and/or homework.

Groups/Cohorts

Assigned Interventions

1

usual care (UC) which is the standard care that patients receive

Behavioral: questionnaires

Participants randomized to the Usual Care arm will receive standard care (the care that participants receive who are not in the intervention). These individuals will not receive any additional therapy sessions from the study interventionists until they are done with the follow up interviews and then it will be offered to them. Follow up questionnaires will assess all study participants at 2 and 4 months after baseline.

2

Cancer Survivorship Intervention-Sexual Health (CSI-SH)plus Usual Care (US)

Behavioral: CSI-SH- Cancer Survivorship Intervention

This involves four 1-hour face-to-face individual sessions with three additional telephone booster/review sessions provided in between the four face-to-face sessions.The face-to-face sessions also include homework assignments that will be reviewed at the subsequent session. Topics covered in the face-to-face sessions are reviewed in the booster telephone calls with the participant the following week. These telephone calls serve as a practice reminder for the participant as well as to help the participant reduce any barriers to implementing the session strategies and/or homework.

Eligibility

Ages Eligible for Study:	21 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

Colorectal patients

Criteria

Inclusion Criteria:

Female
Had surgery for stage I-III rectal adenocarcinoma at MSKCC
Have no evidence of disease or recurrence
Are two or more years post rectal cancer treatment at MSKCC (We will begin our recruitment with women who are two years to 5 years and 11 months posttreatment. We will recruit women 6 or more years post treatment as needed to reach our sample size requirements).
In the judgment of the consenting professional, able to communicate in English well enough to work with English speaking therapists and complete the study assessments.
Age 21 years or older.

Exclusion Criteria:

Participant determined geographical inaccessibility to attend therapy sessions.
Significant cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in a psychotherapeutic intervention.
Male

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00712751

Contacts

Contact: Katherine DuHamel, PhD		duhamelk@mskcc.org
Contact: Jeanne Carter, PhD		carterj@mskcc.org

Locations

United States, New York
Memorial Sloan-Kettering Cancer Center	Recruiting
New York, New York, United States, 10065
Contact: Katherine DuHamel, PhD duhamelk@mskcc.org
Contact: Jeanne Carter, PhD carterj@mskcc.org
Principal Investigator: Katherine DuHamel, PhD

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

Albert Einstein College of Medicine of Yeshiva University

Mount Sinai School of Medicine

National Cancer Institute (NCI)

Investigators

Principal Investigator:

Katherine DuHamel, PhD

Memorial Sloan-Kettering Cancer Center

More Information

Memorial Sloan-Kettering Cancer Center This link exits the ClinicalTrials.gov site

Responsible Party:	Memorial Sloan-Kettering Cancer Center ( Katherine DuHamel, PhD )
Study ID Numbers:	08-073
Study First Received:	July 7, 2008
Last Updated:	November 5, 2008
ClinicalTrials.gov Identifier:	NCT00712751
Health Authority:	United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:

Rectum
Quality of Life
Sexual Health

Study placed in the following topic categories:

Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Rectal Neoplasms
Quality of Life
Gastrointestinal Neoplasms

Intestinal Diseases
Rectal cancer
Rectal Diseases
Intestinal Neoplasms
Colorectal Neoplasms
Rectal neoplasm

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 14, 2009